Luther King Capital Management (LKCM)’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,481
| Closed | -$806K | – | 596 |
|
|
2023
Q1 | $806K | Sell |
35,481
-825
| -2% | -$18.7K | ﹤0.01% | 411 |
|
|
2022
Q4 | $855K | Sell |
36,306
-9,540
| -21% | -$225K | ﹤0.01% | 394 |
|
|
2022
Q3 | $1.2M | Hold |
45,846
| – | – | 0.01% | 353 |
|
|
2022
Q2 | $1.01M | Sell |
45,846
-60,254
| -57% | -$1.32M | 0.01% | 387 |
|
|
2022
Q1 | $4.76M | Sell |
106,100
-2,930
| -3% | -$131K | 0.02% | 204 |
|
|
2021
Q4 | $4.67M | Buy |
109,030
+19,940
| +22% | +$855K | 0.02% | 213 |
|
|
2021
Q3 | $5.92M | Buy |
89,090
+4,886
| +6% | +$325K | 0.03% | 186 |
|
|
2021
Q2 | $6.18M | Buy |
84,204
+4,224
| +5% | +$310K | 0.03% | 185 |
|
|
2021
Q1 | $5.48M | Buy |
79,980
+35,140
| +78% | +$2.41M | 0.03% | 188 |
|
|
2020
Q4 | $3.01M | Sell |
44,840
-1,360
| -3% | -$91.3K | 0.02% | 236 |
|
|
2020
Q3 | $2.38M | Buy |
46,200
+11,365
| +33% | +$585K | 0.02% | 240 |
|
|
2020
Q2 | $1.31M | Buy |
+34,835
| New | +$1.31M | 0.01% | 290 |
|